Rare diseases
Investigational molecules
Locations
Rcsi House, 121 Saint Stephen's Green, D02 H903 Dublin, Ireland
Research activity includes early-stage HER2-positive breast cancer, hormone receptor-positive and HER2-negative breast cancer with low recurrence score, and node-positive breast cancer with 1-3 positive nodes. The funded trials focus on neoadjuvant therapy, endocrine therapy, and decisions about the role of chemotherapy in recurrence risk.
Clinical interest also extends to treatment selection guided by tumour biology and risk of relapse.
Cancer Trials Ireland runs clinical trials in conditions such as Prostate cancer, Squamous cell carcinoma, Breast cancer, Serous cystadenocarcinoma ovary, among others.
Clinical trials run by this sponsor – those enrolling participants first.
IrelandIrelandIrelandIrelandIreland
Denmark
AustriaIrelandIrelandIrelandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
